HRMY FY 2024 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$715M+22.8% YoY

Gross Profit

$558M78.1% margin

Operating Income

$191M26.7% margin

Net Income

$145M20.4% margin

EPS (Diluted)

$2.51

Cash Flow

Operating Cash Flow

$220M

Free Cash Flow

$219M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$999M

Total Liabilities

$340M

Stockholders' Equity

$659M

Cash & Equivalents

$453M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$715M	$582M	+22.8%
Gross Profit	$558M	$461M	+21.1%
Operating Income	$191M	$192M	-0.6%
Net Income	$145M	$129M	+12.9%